Underwriting AgreementUnderwriting Agreement • April 12th, 2017 • Angiodynamics Inc • Surgical & medical instruments & apparatus • New York
The stockholders named in Schedule II hereto (the “Selling Stockholders”) of AngioDynamics, Inc., a Delaware corporation (the “Company”), propose, subject to the terms and conditions stated herein, to sell to Barclays Capital Inc. as set forth in Schedule I hereto (the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof, and to the extent there is only a single underwriter, the term “Underwriters” shall be deemed to refer to the single Underwriter, mutatis mutandis) an aggregate of 2,350,000 shares (the “Shares”) of Common Stock, par value $0.01 (“Stock”) of the Company.
